Loading...
Loading...
Sunesis Pharmaceuticals
SNSS shares slipped 63.10% to $2.45 in pre-market trading as pivotal Phase 3 VALOR trial of acute myeloid leukemia treatment did not meet primary endpoint.
Alcobra
ADHD dropped 40.04% to $8.46 in pre-market trading following the announcement of topline results from Phase III study of MDX in adult ADHD.
EZchip Semiconductor
EZCH shares dropped 8.94% to $22.52 in pre-market trading after the company lowered its Q3 sales forecast.
H&R Block
HRB fell 6.10% to $29.73 in pre-market trading as the company announced that the regulatory approval process for the company's deal with BofI Federal Bank won't be completed this year.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in